These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31077761)

  • 1. In vivo biocompatibility, pharmacokinetics, antitumor efficacy, and hypersensitivity evaluation of ionic liquid-mediated paclitaxel formulations.
    Chowdhury MR; Moshikur RM; Wakabayashi R; Tahara Y; Kamiya N; Moniruzzaman M; Goto M
    Int J Pharm; 2019 Jun; 565():219-226. PubMed ID: 31077761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ionic-Liquid-Based Paclitaxel Preparation: A New Potential Formulation for Cancer Treatment.
    Chowdhury MR; Moshikur RM; Wakabayashi R; Tahara Y; Kamiya N; Moniruzzaman M; Goto M
    Mol Pharm; 2018 Jun; 15(6):2484-2488. PubMed ID: 29762034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel biocompatible intraperitoneal drug delivery system increases tolerability and therapeutic efficacy of paclitaxel in a human ovarian cancer xenograft model.
    Vassileva V; Grant J; De Souza R; Allen C; Piquette-Miller M
    Cancer Chemother Pharmacol; 2007 Nov; 60(6):907-14. PubMed ID: 17375303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biocompatible Ionic Liquid-Mediated Micelles for Enhanced Transdermal Delivery of Paclitaxel.
    Ali MK; Moshikur RM; Wakabayashi R; Moniruzzaman M; Goto M
    ACS Appl Mater Interfaces; 2021 May; 13(17):19745-19755. PubMed ID: 33891816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel.
    Zhang C; Qu G; Sun Y; Wu X; Yao Z; Guo Q; Ding Q; Yuan S; Shen Z; Ping Q; Zhou H
    Biomaterials; 2008 Mar; 29(9):1233-41. PubMed ID: 18093646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paclitaxel in tyrosine-derived nanospheres as a potential anti-cancer agent: in vivo evaluation of toxicity and efficacy in comparison with paclitaxel in Cremophor.
    Sheihet L; Garbuzenko OB; Bushman J; Gounder MK; Minko T; Kohn J
    Eur J Pharm Sci; 2012 Feb; 45(3):320-9. PubMed ID: 22155544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-cancer, pharmacokinetic and biodistribution studies of cremophor el free alternative paclitaxel formulation.
    Jain SK; Utreja P; Tiwary AK; Mahajan M; Kumar N; Roy P
    Curr Drug Saf; 2014; 9(2):145-55. PubMed ID: 24369111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposomal paclitaxel induces fewer hematopoietic and cardiovascular complications than bioequivalent doses of Taxol.
    Huang ST; Wang YP; Chen YH; Lin CT; Li WS; Wu HC
    Int J Oncol; 2018 Sep; 53(3):1105-1117. PubMed ID: 29956746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative in vitro properties and clinical pharmacokinetics of Paclitaxel following the administration of taxol(r) and paxene(r).
    Scripture CD; Szebeni J; Loos WJ; Figg WD; Sparreboom A
    Cancer Biol Ther; 2005 May; 4(5):555-60. PubMed ID: 15917657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo pharmacokinetics, biodistribution and anti-tumor effect of paclitaxel-loaded targeted chitosan-based polymeric micelle.
    Rezazadeh M; Emami J; Hasanzadeh F; Sadeghi H; Minaiyan M; Mostafavi A; Rostami M; Lavasanifar A
    Drug Deliv; 2016 Jun; 23(5):1707-17. PubMed ID: 25188785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An alternative paclitaxel microemulsion formulation: hypersensitivity evaluation and pharmacokinetic profile.
    He L; Wang GL; Zhang Q
    Int J Pharm; 2003 Jan; 250(1):45-50. PubMed ID: 12480272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PEGylated graphene oxide for tumor-targeted delivery of paclitaxel.
    Xu H; Fan M; Elhissi AM; Zhang Z; Wan KW; Ahmed W; Phoenix DA; Sun X
    Nanomedicine (Lond); 2015; 10(8):1247-62. PubMed ID: 25955123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Truncated bFGF-mediated cationic liposomal paclitaxel for tumor-targeted drug delivery: improved pharmacokinetics and biodistribution in tumor-bearing mice.
    Wang X; Deng L; Chen X; Pei H; Cai L; Zhao X; Wei Y; Chen L
    J Pharm Sci; 2011 Mar; 100(3):1196-205. PubMed ID: 20860011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor efficacy, tumor distribution and blood pharmacokinetics of chitosan/glyceryl-monooleate nanostructures containing paclitaxel.
    Trickler WJ; Munt DJ; Jain N; Joshi SS; Dash AK
    Nanomedicine (Lond); 2011 Apr; 6(3):437-48. PubMed ID: 21542683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effect of intravesical administration of paclitaxel solubilized with poly(2-methacryloyloxyethyl phosphorylcholine-co-n-butyl methacrylate) in an orthotopic bladder cancer model.
    Tamura K; Kikuchi E; Konno T; Ishihara K; Matsumoto K; Miyajima A; Oya M
    BMC Cancer; 2015 Apr; 15():317. PubMed ID: 25928041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and biodistribution of paclitaxel loaded in pegylated solid lipid nanoparticles after intravenous administration.
    Li R; Eun JS; Lee MK
    Arch Pharm Res; 2011 Feb; 34(2):331-7. PubMed ID: 21380818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving anti-tumor activity with polymeric micelles entrapping paclitaxel in pulmonary carcinoma.
    Gong C; Xie Y; Wu Q; Wang Y; Deng S; Xiong D; Liu L; Xiang M; Qian Z; Wei Y
    Nanoscale; 2012 Sep; 4(19):6004-17. PubMed ID: 22910790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PEG-derivatized octacosanol as micellar carrier for paclitaxel delivery.
    Chu B; Qu Y; Huang Y; Zhang L; Chen X; Long C; He Y; Ou C; Qian Z
    Int J Pharm; 2016 Mar; 500(1-2):345-59. PubMed ID: 26794876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and biodistribution of polymeric micelles of paclitaxel with Pluronic P123.
    Han LM; Guo J; Zhang LJ; Wang QS; Fang XL
    Acta Pharmacol Sin; 2006 Jun; 27(6):747-53. PubMed ID: 16723095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel cathepsin B-sensitive paclitaxel conjugate: Higher water solubility, better efficacy and lower toxicity.
    Liang L; Lin SW; Dai W; Lu JK; Yang TY; Xiang Y; Zhang Y; Li RT; Zhang Q
    J Control Release; 2012 Jun; 160(3):618-29. PubMed ID: 22410114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.